StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

Stock analysts at StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ) in a report released on Sunday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Trading Down 0.9 %

Shares of NYSE:ENZ opened at $0.65 on Friday. Enzo Biochem has a 1 year low of $0.63 and a 1 year high of $1.40. The firm has a fifty day moving average price of $0.84 and a 200 day moving average price of $1.03.

Enzo Biochem (NYSE:ENZ) last posted its earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Hedge Funds Weigh In On Enzo Biochem

A number of hedge funds have recently modified their holdings of ENZ. BBR Partners LLC acquired a new position in Enzo Biochem in the third quarter worth $112,000. Renaissance Technologies LLC grew its holdings in Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after acquiring an additional 64,417 shares during the last quarter. XTX Topco Ltd grew its holdings in Enzo Biochem by 94.5% during the 2nd quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after acquiring an additional 13,735 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after acquiring an additional 11,742 shares in the last quarter. 36.90% of the stock is owned by institutional investors and hedge funds.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.